Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

R.O.-TROPAMIDE 10 MG — DIN 00896446

TROPICAMIDE : 10 MG · RICHMOND PHARMACEUTICALS INC. · LIQUID · wholesale supply in Canada

Health Canada status: CANCELLED POST MARKET

What is R.O.-TROPAMIDE?

R.O.-TROPAMIDE 10 MG contains TROPICAMIDE : 10 MG. It is listed in the Health Canada Drug Product Database under DIN 00896446, held by RICHMOND PHARMACEUTICALS INC., supplied as LIQUID for OPHTHALMIC administration. Health Canada currently lists it as cancelled post market, status dated 11-Aug-1997. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.

How much does Tropicamide cost around the world?

Tropicamide is listed on 8 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.

What a market publishes matters more than the number it publishes. Bahrain publishes a retail (max); Belgium publishes a public; Greece publishes a producer price (ex-factory). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.

MarketPrice basis published thereBrandsPacks listedRange
Saudi Arabiapublic55SAR███.██
United Statesacquisition24USD███.██
Bahrainretail (max)22BHD███.██
Greeceproducer price (ex-factory)22EUR███.██
South Africasingle exit price22ZAR███.██
United Arab Emiratespublic11AED███.██
Belgiumpublic11EUR███.██
MoroccoPPV (public price)11MAD███.██

18 pack listings across 16 brand entries and 6 price bases, refreshed 05 Sep 2026. Ranges span every Tropicamide pack in that market, so a high figure is usually a larger pack rather than the same product.

Figures are held for the Nexara team. Cross-market prices are published on incompatible bases and are not an offer, a landed cost, or a guide to what any buyer can obtain. Nexara publishes which markets list the product and on what basis; the numbers stay internal.

Team sign-in

This table is a regulatory record of where the molecule is listed. The DIN on this page is no longer authorized for sale in Canada, so Nexara does not quote it — see the alternatives above.

Is there a generic Tropicamide in Canada, and who makes it?

Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.

7 holders have a Canadian DIN containing Tropicamide, across 10 DINs, of which 4 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.

Market authorization holderDINsMarketedBrand namesPosition
ALCON CANADA INC22MYDRIACYLSourceable in Canada
ODAN LABORATORIES LTD21ODAN-TROPICAMIDESourceable in Canada
BAUSCH & LOMB INC11MINIMS TROPICAMIDESourceable in Canada
PHARMA STULLN INC.20TROPICAMIDENo marketed DIN
PHARMASCIENCE INC10PMS-TROPICAMIDE OPH SLTN 1%No marketed DIN
RICHMOND PHARMACEUTICALS INC.10R.O.-TROPAMIDENo marketed DIN
RIVEX OPHTHALMICS INC.10TROPICAMIDE 1% - LIQ OPH 10MG/MLNo marketed DIN

Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.

How is it supplied and stored?

Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.

Strength on the label10 MG
Dosage formLIQUID
RouteOPHTHALMIC

Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.

Substance and classification

Active substanceTropicamide
ATC codeS01FA06
AHFS class52:24.00
Biosimilar biologicNo

Health Canada record and identifiers

The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.

DIN (8-digit, as used in ordering)00896446
DIN (unpadded, as printed on some documents)896446
Brand nameR.O.-TROPAMIDE
Generic / active ingredientTROPICAMIDE : 10 MG
Market authorization holderRICHMOND PHARMACEUTICALS INC.
Health Canada schedulePrescription
ATC codeS01FA06
ATC anatomical main groupS — Sensory organs
ATC therapeutic subgroupS01FA
Current statusCANCELLED POST MARKET
Status date11-Aug-1997
Original market date1992-12-31 00:00:00
Status sourceLive Health Canada DPD sync

Verify on the primary sources

Health Canada DPD record

What can be used instead?

Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.

1 · Same molecule, other Canadian presentations

4 of 10 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.

ProductStrengthFormHolderHealth Canada statusDIN
MINIMS TROPICAMIDE1 %DROPSBAUSCH & LOMB INCMARKETED02148536
MYDRIACYL1 %SOLUTIONALCON CANADA INCMARKETED00001007
MYDRIACYL0.5 %SOLUTIONALCON CANADA INCMARKETED00000981
ODAN-TROPICAMIDE1 %SOLUTIONODAN LABORATORIES LTDMARKETED00622885
ODAN-TROPICAMIDE0.5 %SOLUTIONODAN LABORATORIES LTDDORMANT00627704
PMS-TROPICAMIDE OPH SLTN 1%1 %DROPSPHARMASCIENCE INCCANCELLED POST MARKET00872946
TROPICAMIDE1 %SOLUTIONPHARMA STULLN INC.DORMANT02023679
TROPICAMIDE0.5 %SOLUTIONPHARMA STULLN INC.DORMANT02023660
TROPICAMIDE 1% - LIQ OPH 10MG/ML10 MGLIQUIDRIVEX OPHTHALMICS INC.CANCELLED POST MARKET02212919

2 · Same class — other molecules in ATC S01FA

MoleculeCanadian brandsDINsMarketedSourceable
TropicamideMINIMS TROPICAMIDE · MYDRIACYL · ODAN-TROPICAMIDE · PMS-TROPICAMIDE OPH SLTN 1% · +3 more104Yes
AtropineALCON ATROPINE · ATROPINE · ATROPINE 1% · ATROPINE ONT 1% · +6 more103Yes
CyclopentolateCYCLOGYL · CYCLOPENTOLATE · DOM-CYCLOPENTOLATE HCL OPHTHALMIC SOLUTION-1% · MINIMS CYCLOPENTOLATE HYDROCHLORIDE · +2 more93Yes
HomatropineISOPTO HOMATROPINE 2% · ISOPTO HOMATROPINE 5% · MINIMS HOMATROPINE HYDROBROMIDE 2%30Not in Canada
Tropicamide, CombinationsDIOPHENYL-T SOLUTION · PHENYLTROPE OPH SOLN20Not in Canada

A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.

3 · Adjacent classes in ATC S01F

ATC subgroupMoleculesDINsMarketed
S01FBPhenylephrine53

Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.

What else is R.O.-TROPAMIDE called?

Also recorded in Canada as: p-hydroxyamphetamine 10 MG/ML / tropicamide 2.5 MG/ML Ophthalmic Solution [Paremyd] (US), tropicamide 10 MG/ML Ophthalmic Solution [Mydriacyl] (US), phenylephrine hydrochloride 25 MG/ML / tropicamide 10 MG/ML Ophthalmic Spray [Mydcombi] (US), p-hydroxyamphetamine 10 MG/ML / tropicamide 2.5 MG/ML Ophthalmic Solution (US), phenylephrine hydrochloride 25 MG/ML / tropicamide 10 MG/ML Ophthalmic Spray (US), tropicamide 5 MG/ML Ophthalmic Solution (US), tropicamide 10 MG/ML Ophthalmic Solution (US), HYDROXYAMPHETAMINE HYDROBROMIDE, TROPICAMIDE (US), TROPICAMIDE (US), TROPICAMIDE - PROPARACINE - PHENYLEPHRINE - KETOROLAC (US), TROPICAMIDE AND PHENYLEPHRINE HYDROCHLORIDE (US), Tropicamide (GLOBAL), Mydriacyl (US), Tropicacyl (US), Minims Tropicamide (UK).

The same molecule, Tropicamide, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:

NameScriptRegistered in
MINIMS TROPICAMIDELatinBahrain
MydraneLatinSaudi Arabia
MYDRIACYLLatinBahrain
MYDRIATICUMLatinMorocco

Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.

Can this still be bought in Canada?

No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.

If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Why is there no price on this page?

Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Sources and disclaimer

Product data sourced from the Health Canada Drug Product Database. Health Canada status reconciled against the live DPD sync. Last reviewed 10 Sep 2026.

Nothing on this page is medical advice. Nexara Health is a licensed wholesale distributor and supplies licensed entities only; consumer orders are routed to a partner pharmacy. Alternatives tables describe supply, not clinical equivalence.

Health Canada Drug Product Database (DPD), DIN 00896446. Last reviewed 2026-09-10. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.